Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Kress, B.C.; Freeze, H.H.; Herd, J.K.; Alhadeff, J.A.; Miller, A.L.
    Purification and characterization of I-cell disease alpha-L-fucosidase (1980), J. Biol. Chem., 255, 955-961.
    View publication on PubMed

KM Value [mM]

EC Number KM Value [mM] KM Value Maximum [mM] Substrate Comment Organism Structure
3.2.1.51 0.05 0.06 4-methylumbelliferyl-alpha-L-fucopyranoside
-
 Homo sapiens

Organism

EC Number Organism UniProt Comment Textmining
3.2.1.51 Homo sapiens
-
-
-

Posttranslational Modification

EC Number Posttranslational Modification Comment Organism
3.2.1.51 glycoprotein altered carbohydrate composition from enzymes of liver I-cell disease or pseudo-Hurler polydystrophy urine samples Homo sapiens

Purification (Commentary)

EC Number Purification (Comment) Organism
3.2.1.51 to homogeneity, affinity chromatography Homo sapiens

Source Tissue

EC Number Source Tissue Comment Organism Textmining
3.2.1.51 liver normal and I-cell disease samples Homo sapiens
-
3.2.1.51 urine samples from pseudo-Hurler polydystrophy Homo sapiens
-

Specific Activity [micromol/min/mg]

EC Number Specific Activity Minimum [µmol/min/mg] Specific Activity Maximum [µmol/min/mg] Comment Organism
3.2.1.51 39.7
-
-
 Homo sapiens

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
3.2.1.51 4-methylumbelliferyl-alpha-L-fucopyranoside + H2O
-
 Homo sapiens 4-methylumbelliferone + alpha-L-fucose
-
 ?

pH Optimum

EC Number pH Optimum Minimum pH Optimum Maximum Comment Organism
3.2.1.51 3.9 4 major pH-optimum Homo sapiens
3.2.1.51 6.9
-
 second minor pH-optimum Homo sapiens